Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 8, 2007
[Antiphospholipid syndrome and preeclampsia]G Romano, E Gremese, Clinical and Experimental Immunology|August 24, 2017
B cell activating factor (BAFF) and BAFF receptors: fakes and factsG Ferraccioli, E GremeseEuropean Review for Medical and Pharmacological Sciences|February 24, 2006
Biological therapies in autoimmune chronic inflammatory diseases (ACIDs)G F Ferraccioli, E GremeseClinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of cyclosporine in rheumatoid arthritisE Gremese, G F FerraccioliReumatismo|April 22, 2011
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infectionsA Laria, A Zoli, E Gremese, et al.Reumatismo|August 17, 2004
[Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients peripheral blood mononuclear cells stimulated with lipopolysaccharide]M Fabris, B Tolusso, E Gremese, et al.Pharmacological Research|February 8, 2000
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapyM Baraldo, G Ferraccioli, F Pea, et al.Reumatismo|September 27, 2003
[Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE]P Tomietto, V Annese, S D'Agostini, et al.Reumatismo|September 16, 2024
Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatologyM Manara, D Bruno, M Ferrito, et al.Rheumatology (Oxford, England)|August 3, 2002
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three yearsG F Ferraccioli, E Gremese, P Tomietto, et al.Pageof 3